China Merchants Capital

Portfolio Companies 2026 for China Merchants Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

China Merchants Capital accounts for 9 tracked companies with verified cap-table data, 9 of which disclose round sizes totalling $1.6B. The median disclosed raise is $116M, and the largest is Ouyeel at $434M, ahead of Beijing Weilan New Energy Technology ($286M) and GenScript ProBio ($240M).

The names that recur most often on these portfolio cap tables are China Merchants Capital (9 companies), CCB Principal Capital Management (2 companies), Decheng Capital (2 companies), Baogang International (1 company), Baosteel Group (1 company), Benxi Steel Group (1 company). By latest disclosed round, the market skews Series B (3), Series D (2), Series C (2), Series A (1).

Best funded China Merchants Capital companies

  1. Ouyeel — $434M
  2. Beijing Weilan New Energy Technology — $286M (latest: Series D)
  3. GenScript ProBio — $240M (latest: Series C)
  4. Meike Solar — $236M (latest: Series B)
  5. Freda Biological — $116M (latest: Series B)
  6. AnHeart Therapeutics — $100M (latest: Series A)
  7. Porton Advanced Solutions — $80M (latest: Series B)
  8. KeChow Pharma — $76M (latest: Series D)
  9. Shanghai Kedu Medical Technology — $60M (latest: Series C)

China Merchants Capital — related firms and companies (52)

China Merchants Capital alternatives · All research reports